SciencemRNA Cancer Vaccine Halts Melanoma in Phase 3 TrialModerna and Merck's personalized mRNA vaccine stopped melanoma returning post-surgery in a landmark Phase 3 trial of 1,000 high-risk patients.
TechnologymRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% After Five YearsNew five-year data from the KEYNOTE-942 trial shows Moderna's personalized mRNA vaccine intismeran, paired with Keytruda, nearly halves the risk of melanoma returning after surgery.
ScienceAsthma Drug Montelukast May Fight Aggressive Cancers, Study FindsNorthwestern researchers found that a common asthma medication can switch off the molecule tumors use to evade the immune system, restoring response to immunotherapy in tough cancers.
